Pilulka Lékárny a.s. has completed an IPO on START Market of the Prague Stock Exchange
Pilulka Lékárny a.s. has completed an IPO on START Market of the Prague Stock Exchange consisting of capital increase and disposal of secondary shares.
Founded in 2013, Pilulka is one of the most significant players consolidating the online and offline pharmacy markets in Central Europe. Pilulka is the number one pharmacy e-shop in the home delivery segment in the Czech Republic and Slovakia, and among the top three retail pharmacy chains in the Czech Republic, with 152 branded pharmacies. The company entered the Romanian online pharmacy market in 2018 and plans to expand to Hungary in 2021. Pilulka is a data-driven market disruptor leveraging its tailor-made and easily scalable IT solutions. Furthermore, the company is backed by a strong management team led by Czech e-commerce tycoons Petr and Martin Kasa, who founded the company.
Oaklins’ team in the Czech Republic acted as IPO manager in this transaction. The team succeeded in attracting orders from high-net-worth individuals and experienced investors, and also from a broad range of retail and institutional investors.
Talk to the deal team
DirectorPrague, Czech Republic
Oaklins WOOD & Co.
AssociatePrague, Czech Republic
Oaklins WOOD & Co.
OFFIX Holding and Office World Holding bundled their activities into the newly formed JV Office World Group
OFFIX Holding AG and Office World Holding AG have bundled their businesses into the newly founded Office World Group AG. Office World Holding brings its subsidiaries Office World, iba and Tramondi, and OFFIX brings its companies Papedis, Ecomedia, Oridis, Office Leader and DocuServ into the new Office World Group AG. The merger creates a Swiss group that will be represented throughout the country, generating sales of approximately US$400 million with just under 600 employees.Learn more
CAPZA and RAISE Impact have invested in Oui Care to accelerate its internal and external growth strategies
The shareholders and management of Oui Care have raised funds and restructured its debt for up to US$78.5 million (US$42.2 million for external growth and US$36.3 million in refinancing). This investment will support Oui Care and its management in this new stage of development.Learn more
Hardford has sold its wholly owned subsidiary Hardford Brands to Pharmaxim
Hardford Holding AB has sold Hardford Brands AB to Pharmaxim AB.Learn more